PATRICIA MCMULLEN: Open Payments
NPI 1538329420 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 6 payments from 5 companies in 2025. Trend: 2023 $810 · 2024 $584 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $239 |
| Medtronic, Inc. | 1 | $149 |
| Madrigal Pharmaceuticals | 1 | $124 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Novo Nordisk Inc | 1 | $122 |
Products named: Opzelura, SYMPLICITY G3, REZDIFFRA, AREXVY, Wegovy.
Industry payments across NY — which companies pay providers there.
